title: Pathological examination of breast cancer biomarkers: current status in Japan.
abstract: This article reviews the current status of pathological evaluation for biomarkers in Japan. The introduced issues are the international trends for estimation of biomarkers considering diagnosis and treatment decision, and pathological issues under discussion, and how Japanese Breast Cancer Society (JBCS) members have addressed issues related to pathology and biomarkers evaluation. As topics of immunohistochemical study, (1) ASCO/CAP guidelines, (2) Ki67 and other markers, (3) quantification and image analysis, (4) application of cytologic samples, (5) pre-analytical process, and (6) Japan Pathology Quality Assurance System are introduced. Various phases of concepts, guidelines, and methodologies are co-existed in today's clinical practice. It is expected in near future that conventional methods and molecular procedures will be emerged, and Japanese Quality assurance/Quality control (QA/QC) system will work practically. What we have to do in the next generation are to validate novel procedures, to evaluate the relationship between traditional concepts and newly proposed ideas, to establish a well organized QA/QC system, and to standardize pre-analytical process that are the basis of all procedures using pathological tissues.
authors.affiliation: Department of Pathology, Nihon University School of Medicine, Ohyaguchikami-cho, Itabashi-Ku, Tokyo, 173-8610, Japan. masuda.shinobu@nihon-u.ac.jp.
authors.forename: Shinobu
authors.initials: S
authors.lastname: Masuda
mesh_terms: D014408:Biomarkers, Tumor / Q000032:analysis*; D001943:Breast Neoplasms / Q000175:diagnosis / Q000378:metabolism / Q000473:pathology* / Q000628:therapy; D005260:Female; D017408:Guidelines as Topic; D006801:Humans; D007150:Immunohistochemistry / Q000379:methods*; D007564:Japan; D019394:Ki-67 Antigen / Q000032:analysis; D010338:Pathology, Clinical / Q000592:standards*; D011786:Quality Control
chemical_list: D014408:Biomarkers, Tumor; D019394:Ki-67 Antigen
keywords: Biomarker; Breast cancer; Immunohistochemistry; Japanese Breast Cancer Society